UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 114

Sortiert nach

PINP as a biological response marker during teriparatide treatment for osteoporosis

Osteoporosis international, 2014-09, Vol.25 (9), p.2159-2171

2014

Volltextzugriff (PDF)

Enhanced prediction of fracture risk combining vertebral fracture status and BMD

Osteoporosis international, 2007-06, Vol.18 (6), p.761-770

2007

Volltextzugriff (PDF)

Teriparatide and the risk of nonvertebral fractures in women with postmenopausal osteoporosis

Bone (New York, N.Y.), 2012-01, Vol.50 (1), p.161-164

2012

Volltextzugriff (PDF)

Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States

Osteoporosis international, 2017-03, Vol.28 (3), p.799-809

2017

Volltextzugriff (PDF)

Safety findings from CENTURION, a phase 3 consistency study of lasmiditan for the acute treatment of migraine

Journal of headache and pain, 2021-12, Vol.22 (1), p.132-132, Article 132

2021

Volltextzugriff (PDF)

Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment

Osteoporosis international, 2007, Vol.18 (1), p.59-68

2007

Volltextzugriff (PDF)

Teriparatide for osteoporosis: importance of the full course

Osteoporosis international, 2016-08, Vol.27 (8), p.2395-2410

2016

Volltextzugriff (PDF)

Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis

Osteoporosis international, 2009-06, Vol.20 (6), p.943-948

2009

Volltextzugriff (PDF)

Effects of Arzoxifene on Bone Mineral Density and Endometrium in Postmenopausal Women with Normal or Low Bone Mass

The journal of clinical endocrinology and metabolism, 2009-07, Vol.94 (7), p.2284-2289

2009

Volltextzugriff (PDF)

Effects of raloxifene and alendronate on bone turnover as assessed by procollagen type I N-terminal propeptide

Osteoporosis international, 2011-06, Vol.22 (6), p.1927-1934

2011

Volltextzugriff (PDF)

Spine fracture prevalence in a nationally representative sample of US women and men aged ≥40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013-2014

Osteoporosis international, 2017-06, Vol.28 (6), p.1857-1866

2017

Volltextzugriff (PDF)

Estrogen Inhibits the Vascular Injury Response in Estrogen Receptor β -Deficient Female Mice

Proceedings of the National Academy of Sciences - PNAS, 1999-12, Vol.96 (26), p.15133-15136

1999

Volltextzugriff (PDF)

Reduction in the risk of developing back pain persists at least 30 months after discontinuation of teriparatide treatment : a meta-analysis

Osteoporosis international, 2006-11, Vol.17 (11), p.1630-1637

2006

Volltextzugriff (PDF)

A Noninvasive Computerized Tail-Cuff System for Measuring Blood Pressure in Mice

Hypertension (Dallas, Tex. 1979), 1995-05, Vol.25 (5), p.1111-1115

1995

Volltextzugriff (PDF)

The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures

Osteoporosis international, 2012-08, Vol.23 (8), p.2141-2150

2012

Volltextzugriff (PDF)

Male-female differences in fertility and blood pressure in ACE-deficient mice

Nature (London), 1995-05, Vol.375 (6527), p.146-148

1995

Volltextzugriff (PDF)

Genetic Control of Blood Pressure and the Angiotensinogen Locus

Proceedings of the National Academy of Sciences - PNAS, 1995-03, Vol.92 (7), p.2735-2739

1995

Volltextzugriff (PDF)

Teriparatide fracture effectiveness in the real world

Osteoporosis international, 2015-08, Vol.26 (8), p.2217-2218

2015

Volltextzugriff (PDF)

A simple method for determining the probability a new vertebral fracture is present in postmenopausal women with osteoporosis

Osteoporosis international, 2006-03, Vol.17 (3), p.379-386

2006

Volltextzugriff (PDF)

Combination Teriparatide and Raloxifene Therapy for Postmenopausal Osteoporosis: Results From a 6‐Month Double‐Blind Placebo‐Controlled Trial

Journal of bone and mineral research, 2005-11, Vol.20 (11), p.1905-1911

2005

Volltextzugriff (PDF)

Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate

Osteoporosis international, 2008-07, Vol.19 (7), p.1055-1065

2008

Volltextzugriff (PDF)

ACE gene titration in mice uncovers a new mechanism for ACE on the control of body weight

Physiological genomics, 2005-01, Vol.20 (2), p.173-182

2005

Volltextzugriff (PDF)

Generation and Reproductive Phenotypes of Mice Lacking Estrogen Receptor β

Proceedings of the National Academy of Sciences - PNAS, 1998-12, Vol.95 (26), p.15677-15682

1998

Volltextzugriff (PDF)

Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study

Osteoporosis international, 2016-03, Vol.27 (3), p.1191-1198

2016

Volltextzugriff (PDF)

Prognostic utility of a semiquantitative spinal deformity index

Bone (New York, N.Y.), 2005-08, Vol.37 (2), p.175-179

2005

Volltextzugriff (PDF)

1 – 25 von 114

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(105)

Publikationsform

Artikel
(110)
Webseiten
(4)

Sprache

Englisch
(97)
Deutsch
(17)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PINP as a biological response marker during teriparatide treatment for osteoporosis

Enhanced prediction of fracture risk combining vertebral fracture status and BMD

Teriparatide and the risk of nonvertebral fractures in women with postmenopausal osteoporosis

Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States

Safety findings from CENTURION, a phase 3 consistency study of lasmiditan for the acute treatment of migraine

Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment

Teriparatide for osteoporosis: importance of the full course

Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis

Effects of Arzoxifene on Bone Mineral Density and Endometrium in Postmenopausal Women with Normal or Low Bone Mass

Effects of raloxifene and alendronate on bone turnover as assessed by procollagen type I N-terminal propeptide

Spine fracture prevalence in a nationally representative sample of US women and men aged ≥40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013-2014

Estrogen Inhibits the Vascular Injury Response in Estrogen Receptor β -Deficient Female Mice

Reduction in the risk of developing back pain persists at least 30 months after discontinuation of teriparatide treatment : a meta-analysis

A Noninvasive Computerized Tail-Cuff System for Measuring Blood Pressure in Mice

The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures

Male-female differences in fertility and blood pressure in ACE-deficient mice

Genetic Control of Blood Pressure and the Angiotensinogen Locus

Teriparatide fracture effectiveness in the real world

A simple method for determining the probability a new vertebral fracture is present in postmenopausal women with osteoporosis

Combination Teriparatide and Raloxifene Therapy for Postmenopausal Osteoporosis: Results From a 6‐Month Double‐Blind Placebo‐Controlled Trial

Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate

ACE gene titration in mice uncovers a new mechanism for ACE on the control of body weight

Generation and Reproductive Phenotypes of Mice Lacking Estrogen Receptor β

Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study

Prognostic utility of a semiquantitative spinal deformity index

Suchergebnisse filtern